 | Related Articles |
New Evidence Supporting Cyclosporine Efficacy in Epidermal Necrolysis.
J Invest Dermatol. 2017 Oct;137(10):2047-2049
Authors: Roujeau JC, Mockenhaupt M, Guillaume JC, Revuz J
Abstract
Sixty years after its original description by Sir Alan Lyell, epidermal necrolysis (from Stevens-Johnson syndrome to toxic epidermal necrolysis) seems finally amenable to a specific treatment in addition to essential symptomatic measures in specialized settings. A recently published systematic review and an article by Gonzales-Herrada et al. strongly suggest that cyclosporine is effective in reducing the risk of death.
PMID: 28941473 [PubMed - indexed for MEDLINE]
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2ykHEmd
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,